222 related articles for article (PubMed ID: 17659253)
1. Enhancing exposure-based therapy from a translational research perspective.
Hofmann SG
Behav Res Ther; 2007 Sep; 45(9):1987-2001. PubMed ID: 17659253
[TBL] [Abstract][Full Text] [Related]
2. D-cycloserine augmentation of behavior therapy for anxiety and obsessive-compulsive disorders: A meta-analysis.
Bürkner PC; Bittner N; Holling H; Buhlmann U
PLoS One; 2017; 12(3):e0173660. PubMed ID: 28282427
[TBL] [Abstract][Full Text] [Related]
3. Anxiety and alcohol use disorders: comorbidity and treatment considerations.
Smith JP; Randall CL
Alcohol Res; 2012; 34(4):414-31. PubMed ID: 23584108
[TBL] [Abstract][Full Text] [Related]
4. Deep brain stimulation, histone deacetylase inhibitors and glutamatergic drugs rescue resistance to fear extinction in a genetic mouse model.
Whittle N; Schmuckermair C; Gunduz Cinar O; Hauschild M; Ferraguti F; Holmes A; Singewald N
Neuropharmacology; 2013 Jan; 64(4):414-23. PubMed ID: 22722028
[TBL] [Abstract][Full Text] [Related]
5. D-Cycloserine as an augmentation strategy for cognitive behavioral therapy of anxiety disorders.
Hofmann SG; Wu JQ; Boettcher H
Biol Mood Anxiety Disord; 2013 Jun; 3(1):11. PubMed ID: 23768232
[TBL] [Abstract][Full Text] [Related]
6. A high-throughput clinical assay for testing drug facilitation of exposure therapy.
Rodebaugh TL; Levinson CA; Lenze EJ
Depress Anxiety; 2013 Jul; 30(7):631-7. PubMed ID: 23283838
[TBL] [Abstract][Full Text] [Related]
7. Cognitive-Behavioral Therapy Enhancement Strategies.
Tolin DF; Lord KA; Knowles KA
Psychiatr Clin North Am; 2024 Jun; 47(2):355-365. PubMed ID: 38724125
[TBL] [Abstract][Full Text] [Related]
8. Enhancing panic and smoking reduction treatment with d-cycloserine: Study protocol for a randomized controlled trial.
Smits JA; Kauffman BY; Lee-Furman E; Zvolensky MJ; Otto MW; Piper ME; Powers MB; Rosenfield D
Contemp Clin Trials; 2016 May; 48():46-51. PubMed ID: 27015966
[TBL] [Abstract][Full Text] [Related]
9. Maximizing exposure therapy: an inhibitory learning approach.
Craske MG; Treanor M; Conway CC; Zbozinek T; Vervliet B
Behav Res Ther; 2014 Jul; 58():10-23. PubMed ID: 24864005
[TBL] [Abstract][Full Text] [Related]
10. The Future of D-Cycloserine and Other Cognitive Modifiers in Obsessive-Compulsive and Related Disorders.
Sulkowski ML; Geller DA; Lewin AB; Murphy TK; Mittelman A; Brown A; Storch EA
Curr Psychiatry Rev; 2014; 10(4):317-324. PubMed ID: 25383074
[TBL] [Abstract][Full Text] [Related]
11. Singular and combined effects of transcranial infrared laser stimulation and exposure therapy: A randomized clinical trial.
Zaizar ED; Gonzalez-Lima F; Telch MJ
Contemp Clin Trials; 2018 Sep; 72():95-102. PubMed ID: 30092284
[TBL] [Abstract][Full Text] [Related]
12. Exploring exercise as an avenue for the treatment of anxiety disorders.
DeBoer LB; Powers MB; Utschig AC; Otto MW; Smits JA
Expert Rev Neurother; 2012 Aug; 12(8):1011-22. PubMed ID: 23002943
[TBL] [Abstract][Full Text] [Related]
13. Combined Pharmacotherapy and Cognitive-Behavioral Therapy for Anxiety Disorders: Medication Effects, Glucocorticoids, and Attenuated Treatment Outcomes.
Otto MW; McHugh RK; Kantak KM
Clin Psychol (New York); 2010 Jun; 17(2):91-103. PubMed ID: 26855480
[TBL] [Abstract][Full Text] [Related]
14. CO
Smits JAJ; Monfils MH; Otto MW; Telch MJ; Shumake J; Feinstein JS; Khalsa SS; Cobb AR; Parsons EM; Long LJ; McSpadden B; Johnson D; Greenberg A;
BMC Psychiatry; 2022 Dec; 22(1):831. PubMed ID: 36575425
[TBL] [Abstract][Full Text] [Related]
15. Intra-mPFC injection of sodium butyrate promotes BDNF expression and ameliorates extinction recall impairment in an experimental paradigm of post-traumatic stress disorder.
Mohammadi-Farani A; Fakhri S; Jalili C; Samimi Z
Iran J Basic Med Sci; 2022 Sep; 25(9):1150-1158. PubMed ID: 36246060
[TBL] [Abstract][Full Text] [Related]
16. Timing of vagus nerve stimulation during fear extinction determines efficacy in a rat model of PTSD.
Souza RR; Powers MB; Rennaker RL; McIntyre CK; Hays SA; Kilgard MP
Sci Rep; 2022 Oct; 12(1):16526. PubMed ID: 36192564
[TBL] [Abstract][Full Text] [Related]
17. A Case for Translation From the Clinic to the Laboratory.
Kredlow MA; de Voogd LD; Phelps EA
Perspect Psychol Sci; 2022 Jul; 17(4):1120-1149. PubMed ID: 35245166
[TBL] [Abstract][Full Text] [Related]
18. Transcranial Electric Stimulation and the Extinction of Fear.
Adams T; Wesley M; Rippey C
Clin Psychol; 2020; 73(4):5-14. PubMed ID: 35153300
[No Abstract] [Full Text] [Related]
19. Effects of ∆
Raymundi AM; da Silva TR; Sohn JMB; Bertoglio LJ; Stern CA
BMC Psychiatry; 2020 Aug; 20(1):420. PubMed ID: 32842985
[TBL] [Abstract][Full Text] [Related]
20. Facilitative effects of environmental enrichment for cocaine relapse prevention are dependent on extinction training context and involve increased TrkB signaling in dorsal hippocampus and ventromedial prefrontal cortex.
Hastings MH; Gauthier JM; Mabry K; Tran A; Man HY; Kantak KM
Behav Brain Res; 2020 May; 386():112596. PubMed ID: 32194188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
